Enhance lab capability with cobas® c703 and cobas® ISE neo
The FDA has granted clearance of our newest next-generation analytical units, helping to improve laboratory workflows and advance patient care.
Latest news
What is the future for tissue diagnostics in oncology?
Dr. Audrey Bennett shares her expert insights and discusses an industry-leading IVD menu of ready-to-use assays.
Mass spectrometry menu expands to include steroid assays
The FDA has categorized our Ionify® steroid assays for mass spectrometry as CLIA ‘moderate complexity.’
FDA clears the only blood test for primary-care use to rule out Alzheimer's-related amyloid pathology
Bringing this blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner to support them earlier in their journeys.
Featured products
Experience simplicity at scale with high-volume clinical chemistry and 2,000 tests per hour
Experience simplicity at scale with high-volume clinical chemistry and 2,000 tests per hour
Related links
Products
Learn more about our portfolio of lab instruments, systems, assays and more
Documents
More than 800,000 documents available on demand — always up-to-date with 24/7 access
